CN1449818A - 抗非典型性肺炎汤 - Google Patents
抗非典型性肺炎汤 Download PDFInfo
- Publication number
- CN1449818A CN1449818A CN03137968A CN03137968A CN1449818A CN 1449818 A CN1449818 A CN 1449818A CN 03137968 A CN03137968 A CN 03137968A CN 03137968 A CN03137968 A CN 03137968A CN 1449818 A CN1449818 A CN 1449818A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- sars
- effect
- gram
- acute respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002156 mixing Methods 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000405414 Rehmannia Species 0.000 claims abstract 2
- 229910052602 gypsum Inorganic materials 0.000 claims abstract 2
- 239000010440 gypsum Substances 0.000 claims abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 claims 1
- 241000050051 Chelone glabra Species 0.000 claims 1
- 240000005250 Chrysanthemum indicum Species 0.000 claims 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims 1
- 241001660870 Cyrtomium Species 0.000 claims 1
- 241000576429 Forsythia suspensa Species 0.000 claims 1
- 244000111489 Gardenia augusta Species 0.000 claims 1
- 235000018958 Gardenia augusta Nutrition 0.000 claims 1
- 244000246386 Mentha pulegium Species 0.000 claims 1
- 235000016257 Mentha pulegium Nutrition 0.000 claims 1
- 235000004357 Mentha x piperita Nutrition 0.000 claims 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims 1
- 240000003582 Platycodon grandiflorus Species 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 235000001050 hortel pimenta Nutrition 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 15
- 241000555682 Forsythia x intermedia Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 241000245240 Lonicera Species 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 description 11
- 235000014347 soups Nutrition 0.000 description 11
- 241000628997 Flos Species 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种抗非典型性肺炎汤，将以下各味药材混合水煎制成：黄芩：0.5～10重量份，栀子：0.5～10重量份，金银花：0.5～10重量份，连翘：0.5～10重量份，生地：0.5～10重量份，生石膏：0.5～10重量份，野菊花：0.5～10重量份，贯众：0.5～10重量份，桔梗：0.5～10重量份，薄荷：0.5～10重量份，牛子：0.5～10重量份，甘草：0.5～10重量份。本发明的抗非典型性肺炎汤对预防和治疗SARS或疑似SARS具有良好的效果。
Description
技术领域
本发明涉及中药领域，具体地说，是涉及一种中药复方制剂，即抗非典型性肺炎汤。
背景技术
非典型性肺炎(SARS)是一种由冠状病毒引起的传染性极强的疾病。2002年起在全世界特别是在中国流行，已经造成近万人感染、相当多的人死亡。虽然各国都投入了大量人力和财力进行研究，但是迄今为止，在病理学的研究方面尚未取得突破性的进展，其发病原因仍然不明，更没有研制出预防疫苗和特效药。因此西医采用的方法也仅限于强化与患者的隔离，以及凭经验使用传统的手段进行治疗。
在上述情况下，对于非典型性肺炎而言，以解剖学、生物化学等作为基础的西医药，与主要以临床经验作为基础的中医药相比就失去了优势，而积累了几千年经验的中医药在某些方面反而具有西医药不可替代的优点。以北京为例，到目前为止，已有一千余名患者接受了中医或中西医结合方法治疗SARS及其疑似病例，服用中药进行预防的人则不计其数。实践证明，采用中西医结合的方法治疗和预防非典型性肺炎、或者疑似非典型性肺炎能够取得良好的效果，这一点已经得到世界卫生组织(WHO)和世界各国的认同。
虽然非典型性肺炎的发病率可能在一定期间得到控制，但是离彻底消灭还有很长的距离。此外，随着气候等因素的变化，很有可能再次流行。因此迫切需要在现有经验的基础上，提出一种对预防和治疗非典型性肺炎或疑似非典型性肺炎有突出效果的中药复方制剂。
发明内容
鉴于以上情况，本发明要解决的问题，就是提出一种对治疗和预防非典型性肺炎或疑似非典型性肺炎具有突出效果的中药复方制剂，即抗非典型性肺炎汤。
本发明是一种抗非典型性肺炎汤，其特征在于，将以下各味药材混合水煎制成：
黄芩 0.5～10重量份
栀子 0.5～10重量份
金银花 0.5～10重量份
连翘 0.5～10重量份
生地 0.5～10重量份
生石膏 0.5～10重量份
野菊花 0.5～10重量份
贯众 0.5～10重量份
桔梗 0.5～10重量份
薄荷 0.5～10重量份
牛子 0.5～10重量份
甘草 0.5～10重量份
中医学认为，非典型性肺炎和疑似非典型性肺炎均属于湿热疫病的范畴。本发明人根据多年的经验，配制了上述复方制剂。
在上述各味药材中，黄芩：苦寒，具有清热燥湿的作用。栀子：苦寒，具有清热解毒、凉血止血的作用。金银花：甘寒，具有清热解毒的作用。连翘：苦微寒，具有清热解毒、消痈散结的作用。生地：具有凉血、止血的作用。生石膏：甘寒，具有清热泄火、除烦止渴的作用。野菊花：苦凉，具有清热解毒、凉血降压的作用。贯众：苦微寒，有小毒，具有清热、解毒、止血的作用。桔梗：苦辛平，具有祛痰、止咳、排脓、宣肺气的作用。薄荷：辛凉，具有散风热、清头目的作用。牛子(即牛蒡子)：微寒，具有止咳化痰、疏散风热的作用。甘草：甘平，具有润肺止咳、解毒的作用。
本发明的复方制剂不是针对个别患者的处方，而是药效固定的可再现的复方制剂。通过对临床药效资料进行处理分析，结果表明没有显着性个体差异。实践证明，在上述各味药材的协同作用下，本发明的复方制剂对防治SARS或疑似SARS有显着效果。
具体实施方式
实施例1将以下各味药材混合，慢火水煎40分钟得到抗非典型性肺炎汤：黄芩 0.4克栀子 0.6克金银花 0.7克连翘 0.5克生地 0.6克生石膏 0.5克野菊花 0.7克贯众 0.3克桔梗 0.8克薄荷 0.35克牛子 0.45克甘草 0.65克
实施例2将以下各味药材混合，慢火水煎40分钟得到抗非典型性肺炎汤：黄芩 0.85克栀子 0.9克金银花 11克连翘 0.9克生地 10克生石膏 10克野菊花 0.9克贯众 0.8克桔梗 0.7克薄荷 10克牛子 0.7克甘草 11克最后对本发明的抗非典型性肺炎汤的作用作进一步的说明。【预防作用】
受试者共36名，其中未与SARS患者接触的30名，接触过SARS患者的6名。服用上述实施例*的抗非典型性肺炎汤，每日2次，2～4岁的儿童每次75克，4岁以上的人每次150克。共服用10次，结果在36名受试者中没有出现一例被感染发病者。
【治疗作用】
选择病例的标准：SARS患者或疑似SARS患者7名。
诊断标准：用中医方法诊断，症状为持续发烧，干咳，上呼吸困难。
治疗的方案设计：中西医结合治疗。除采用西医的治疗措施外，服用上述实施例1的抗非典型性肺炎汤，每日2次，2～4岁的儿童每次75克，4岁以上的人每次150克。
疗效评定标准：以症状消除作为疗效评定标准。
疗效：喝本发明的抗非典型性肺炎汤10次后，6名患者退烧，止咳，上呼吸顺畅。从开始服用到恢复健康的天数平均为5天。
预防作用：100％有效。
治疗作用：86％显着有效。上述6名被治疗者从开始服用本药至恢复健康的天数平均为5天。而未服用本药的患者恢复健康的天数平均为29天，前者比后者平均少24天。
上述情况充分说明，本发明的抗非典型性肺炎汤对预防和治疗非典型性肺炎或疑似非典型性肺炎具有显着的效果。是一种具备新颖性、创造性、实用性的中药复方制剂。
Claims (1)
1.抗非典型性肺炎汤，其特征在于，将以下各味药材混合水煎制成：黄芩 0.5～10重量份栀子 0.5～10重量份金银花 0.5～10重量份连翘 0.5～10重量份生地 0.5～10重量份生石膏 0.5～10重量份野菊花 0.5～10重量份贯众 0.5～10重量份桔梗 0.5～10重量份薄荷 0.5～10重量份牛子 0.5～10重量份甘草 0.5～10重量份
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031379680A CN1135111C (zh) | 2003-06-13 | 2003-06-13 | 抗非典型性肺炎汤 |
| JP2003273338A JP2005002084A (ja) | 2003-06-13 | 2003-07-11 | 抗新型肺炎の煎じ薬 |
| US10/624,577 US20040253328A1 (en) | 2003-06-13 | 2003-07-21 | Anti-atypical pneumonia decoction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031379680A CN1135111C (zh) | 2003-06-13 | 2003-06-13 | 抗非典型性肺炎汤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1449818A true CN1449818A (zh) | 2003-10-22 |
| CN1135111C CN1135111C (zh) | 2004-01-21 |
Family
ID=28684497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031379680A Expired - Fee Related CN1135111C (zh) | 2003-06-13 | 2003-06-13 | 抗非典型性肺炎汤 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20040253328A1 (zh) |
| JP (1) | JP2005002084A (zh) |
| CN (1) | CN1135111C (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082388A1 (en) * | 2004-02-27 | 2005-09-09 | Phynova Limited | Extracts of scutellaria for the treatment of sars |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101018866B1 (ko) | 2009-03-16 | 2011-03-04 | 퓨리메드 주식회사 | 만성폐쇄성 폐질환 예방 및 치료용 한약조성물 |
| CN104352955A (zh) * | 2014-10-17 | 2015-02-18 | 王洪强 | 一种治疗肺炎的中药 |
| CN108624463A (zh) * | 2018-05-21 | 2018-10-09 | 李红光 | 一种预防流感食醋的配方 |
-
2003
- 2003-06-13 CN CNB031379680A patent/CN1135111C/zh not_active Expired - Fee Related
- 2003-07-11 JP JP2003273338A patent/JP2005002084A/ja active Pending
- 2003-07-21 US US10/624,577 patent/US20040253328A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082388A1 (en) * | 2004-02-27 | 2005-09-09 | Phynova Limited | Extracts of scutellaria for the treatment of sars |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1135111C (zh) | 2004-01-21 |
| US20040253328A1 (en) | 2004-12-16 |
| JP2005002084A (ja) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463609A (zh) | 治疗上呼吸道感染的中药口服汤剂及其中成药的制备方法 | |
| CN1131046C (zh) | 一种治疗小儿肺炎的中药制剂 | |
| CN103041243A (zh) | 一种中药清火排毒祛痘胶囊 | |
| CN104587298A (zh) | 一种治疗肺痈的中药组合物 | |
| CN104208453B (zh) | 一种用于防治草鱼出血病的中药组合物及其制备方法 | |
| CN103933480A (zh) | 一种治疗肺结核的中药 | |
| CN1449818A (zh) | 抗非典型性肺炎汤 | |
| CN1965986A (zh) | 一种治疗病毒性心肌炎的汤剂药物及制备方法 | |
| CN104825960A (zh) | 一种治疗肺结核的中药及其制备方法 | |
| CN1730077A (zh) | 治疗咽喉炎的中药制剂 | |
| CN1107511C (zh) | 一种治疗感冒的药物 | |
| CN1895465A (zh) | 一种治疗急性腮腺炎的汤剂药物及制备方法 | |
| CN103071111A (zh) | 一种治疗冠心病心绞痛的药物组合物及其制备方法 | |
| CN1191086C (zh) | 一种治疗夏秋季感冒的药物 | |
| CN105596695B (zh) | 蒙药棘豆止咳散 | |
| CN1907406A (zh) | 一种治疗久病入络型失眠症的汤剂药物及制备方法 | |
| CN103055172A (zh) | 一种治疗白癜风的中药组合 | |
| CN103100013B (zh) | 治疗支气管扩张症的中药汤剂 | |
| CN103768421A (zh) | 一种止咳化痰的中药制剂 | |
| CN100339125C (zh) | 一种治疗消化系统溃疡的中药组合物 | |
| CN106039075A (zh) | 一种治疗肺胃蕴热型慢性咽炎的中药组合物及方法 | |
| CN1219528C (zh) | 一种治疗毒瘾的中成药 | |
| CN104547581A (zh) | 风湿性腰椎病疏风散寒药酒及制备方法 | |
| CN1103599C (zh) | 一种治疗哮喘病的药物组合物及其制备方法 | |
| Vasilenko | Prospects of Complementary Medicine in Prevention and Treatment of COVID-19: Phytotherapy as a Traditional Chinese Medicine and Ayurveda Technique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: XUE JINGSHU Free format text: FORMER OWNER: HU XINYUAN; WANG XIMING; XUE JINGSHU Effective date: 20060217 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20060217 Address after: 518000 China Guangdong province Shenzhen Baishida garden two cloud Xuan 6-50 Patentee after: Xue Jingshu Address before: 518000 Guangdong city in Shenzhen Province, 100 homestead garden two cloud Xuan 5-7B Co-patentee before: Wang Ximing Patentee before: Hu Xinyuan Co-patentee before: Xue Jingshu |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |